Mr. Xianxian Li is an Executive Director and Rotating CEO of Kaitai Capital. He is responsible for the day-to-day management and operation of Catalin Capital, as well as for small molecule-targeted drug investments and participation in investment management in the field of biomedicine and biomedical sciences. Xianxian graduated from Zhejiang University with a master's degree in engineering.
View in org chart
View in org chart
Current role